Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy
- PMID: 4122012
- DOI: 10.1016/s0140-6736(73)90399-1
Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy
MeSH terms
Substances
LinkOut - more resources
Full Text Sources